Webinar on demand | Innovation-driven commitment to antibacterial discovery
|
At the session on antimicrobial resistance held at the OneNucleus Genesis conference in December 2020, Evotec's VP Anti-infectives Antonio Felici and other field experts discussed how innovation is instrumental in successfully developing new antibacterials. Stream the presentation here! |